Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Frank

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
JAK-STAT|January 29, 2014
JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibitionJennifer E Yeh, Patricia A Toniolo, David A Frank
Carcinogenesis|July 31, 2004
IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptorHanna Yuan, Forrester J Liddle, Sudipta Mahajan, et al.
Neoplasia (New York, N.Y.)|February 11, 2025
STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromesZoe King, Sudhamsh Reddy Desai, David A Frank, et al.
Molecular Pharmacology|August 10, 2010
Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signalingSarah R Walker, Mousumi Chaudhury, Erik A Nelson, et al.
Biochemistry|April 26, 2006
Tyrosine phosphorylation is required for functional activation of disulfide-containing constitutively active STAT mutantsForrester J Liddle, James V Alvarez, Valeria Poli, et al.
Cancer Research|February 7, 2007
A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cellsRebecca A Lynch, Julia Etchin, Traci E Battle, et al.
Oncotarget|June 18, 2011
A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translationErik A Nelson, Sreenath V Sharma, Jeffrey Settleman, et al.
JAK-STAT|September 24, 2013
STAT signaling in the pathogenesis and treatment of myeloid malignanciesMichal Bar-Natan, Erik A Nelson, Michael Xiang, et al.
The Journal of Biological Chemistry|October 23, 2004
Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identificationErik A Nelson, Sarah R Walker, James V Alvarez, et al.
Leukemia Research|June 14, 2003
Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysisTraci E Battle, Hugo Castro-Malaspina, John G Gribben, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
JAK-STAT|January 29, 2014
JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibitionJennifer E Yeh, Patricia A Toniolo, David A Frank
Carcinogenesis|July 31, 2004
IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptorHanna Yuan, Forrester J Liddle, Sudipta Mahajan, et al.
Neoplasia (New York, N.Y.)|February 11, 2025
STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromesZoe King, Sudhamsh Reddy Desai, David A Frank, et al.
Molecular Pharmacology|August 10, 2010
Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signalingSarah R Walker, Mousumi Chaudhury, Erik A Nelson, et al.
Biochemistry|April 26, 2006
Tyrosine phosphorylation is required for functional activation of disulfide-containing constitutively active STAT mutantsForrester J Liddle, James V Alvarez, Valeria Poli, et al.
Cancer Research|February 7, 2007
A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cellsRebecca A Lynch, Julia Etchin, Traci E Battle, et al.
Oncotarget|June 18, 2011
A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translationErik A Nelson, Sreenath V Sharma, Jeffrey Settleman, et al.
JAK-STAT|September 24, 2013
STAT signaling in the pathogenesis and treatment of myeloid malignanciesMichal Bar-Natan, Erik A Nelson, Michael Xiang, et al.
The Journal of Biological Chemistry|October 23, 2004
Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identificationErik A Nelson, Sarah R Walker, James V Alvarez, et al.
Leukemia Research|June 14, 2003
Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysisTraci E Battle, Hugo Castro-Malaspina, John G Gribben, et al.
Pageof 13